Circulating cell adhesion molecules and death in patients with coronary artery disease

S Blankenberg1, H J Rupprecht, C Bickel

  • 1Department of Medicine II, Johannes Gutenberg-University Mainz, Germany. stefan.blankenberg@uni-mainz.de

Circulation
|September 19, 2001
PubMed

Insights

Higher levels of soluble adhesion molecules, including vascular cell adhesion molecule-1 (sVCAM-1), predict future cardiovascular death in coronary artery disease (CAD) patients. Soluble VCAM-1 is a significant independent predictor of fatal cardiovascular events.

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Biomarkers

Background:

  • Leukocyte adhesion molecules like VCAM-1, ICAM-1, and E-selectin contribute to atherosclerosis progression.
  • These molecules mediate leukocyte adhesion and transmigration, potentially driving plaque instability.

Purpose of the Study:

  • To investigate the association between soluble adhesion molecules and future cardiovascular events in patients with coronary artery disease (CAD).
  • To determine if soluble adhesion molecules improve risk prediction beyond established factors.

Main Methods:

  • Prospective cohort study of 1246 patients with angiographically documented CAD.
  • Baseline measurement of soluble VCAM-1 (sVCAM-1), sICAM-1, and sE-selectin.
  • Follow-up for cardiovascular events over a mean of 2.7 years.

Main Results:

  • Elevated sVCAM-1, sICAM-1, and sE-selectin levels were associated with increased cardiovascular death.
  • Patients in the highest quartile of sVCAM-1 had a 2.1-fold higher risk of fatal events.
  • sVCAM-1 remained an independent predictor of cardiovascular death, even after accounting for inflammation markers like hs-CRP.

Conclusions:

  • Soluble adhesion molecules, particularly sVCAM-1, are significantly linked to future cardiovascular mortality in CAD patients.
  • sVCAM-1 enhances the predictive value of traditional risk factors and hs-CRP for cardiovascular death.
Abstract

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...